Skip to main content
All lobbying filings

Avenue Solutions

Avenue Solutions filed a Q2 report for Vertex Pharmaceuticals Incorporated on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Vertex Pharmaceuticals Incorporated · Biopharmaceutical company

As filed: AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED.

All filings by Avenue Solutions · Everything Vertex Pharmaceuticals Incorporated has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language

Health Issues

Monitor issues related to 340b;

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem